About: Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im März 2000 veröffentlicht worden isch (gsw) im März 2000 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в березні 2000 (uk) article scientifique publié en 2000 (fr) artículu científicu espublizáu en marzu de 2000 (ast) scientific article published on 01 March 2000 (en)
publication date	wds:Q73520895-F9703F3C-9E95-4621-882D-82106DBB7D95
publication date	2000-03-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73520895-0D06D8CB-622F-4284-966C-91661F54BC9F wds:Q73520895-17DFA1D1-AAD5-4483-8492-90B08C58D131 wds:Q73520895-1EBF56F6-E586-4700-815D-5E5DECBDC546 wds:Q73520895-207EB6CB-41E5-4A6D-946A-BCC192EFE019 wds:Q73520895-387A810A-B101-4E13-9504-58E3E39D70D6 wds:Q73520895-46AECFD0-2171-4298-AB5A-03DF53FB2602 wds:Q73520895-54270C06-0724-420E-98FB-35E67551D4C6 wds:Q73520895-57BE5629-46B4-4ABD-8D15-84DFB22323D4 wds:Q73520895-5EF495AA-24DA-4C58-BFAE-E9768502B1D7 wds:Q73520895-64AC4F53-6C1D-48AE-B0AC-CB6F675487D5 wds:Q73520895-6D3F0675-5D8E-47BE-98CD-A1E58DF11A45 wds:Q73520895-705012BD-7700-4973-A9B5-BE93E8A336E5 wds:Q73520895-91D544CA-9F54-4589-BA62-CEC702D374F9 wds:Q73520895-9A194E5E-F02D-4547-BAA1-BCCDBB59A201 wds:Q73520895-ED1BC73E-4ADC-4727-ADFE-3C36699968EA wds:Q73520895-EF1489CD-2206-4049-8E49-F942B29F7DDE
author name string	Bruno B Broccia G Bacigalupo A Locatelli F Dufour C Di Bona E Leoni P Barbui T Locasciulli A Carotenuto M Gabbas A Arcese W Ferster A Saracco P Coser P Testi G
rdfs:label	Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on (en) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on (nl)
skos:prefLabel	Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on (en) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on (nl)
name	Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on (en) Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on (nl)
title	wds:Q73520895-29DDC1CE-82F4-4CF7-BFAB-863C54102B15
title	Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO) (en)
page(s)	wds:Q73520895-CD44AF86-9845-415E-9E1F-27DEFE29203C
page(s)	1931-1934
instance of	wds:Q73520895-D7B4C468-B3D9-4895-B2D6-7FE8DF3E2E83
instance of	scholarly article
main subject	wds:Q73520895-2190DCC7-BED7-4ABF-BB37-F928FAB30167 wds:Q73520895-56ED8B98-F33C-43A1-A865-4ABC6E3AABEE
main subject	aplastic anemia cyclosporine
PubMed ID	wds:Q73520895-BCF2F6F7-B4EA-4697-ADD9-505C1C819149
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10706857
PubMed ID	10706857
published in	wds:Q73520895-CF7D0222-6EAE-48BB-B77F-3793B3A35883
published in	Blood
issue	wds:Q73520895-A9CA6779-334E-4045-9478-282C1E685E5B
volume	wds:Q73520895-5032A072-9575-4B52-9EE5-B2102A7FA087
issue	6
volume	95
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73520895
is cites work of	How I treat acquired aplastic anemia G-CSF and GM-CSF in Neutropenia Horse versus rabbit antithymocyte globulin in acquired aplastic anemia Current concepts in the pathophysiology and treatment of aplastic anemia Immune pathophysiology of aplastic anemia Aplastic anemia Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia Impaired Autophagy in Adult Bone Marrow CD34+ Cells of Patients with Aplastic Anemia: Possible Pathogenic Significance Treatment of severe aplastic anemia by immunosuppressor anti-lymphocyte globulin/anti-thymus globulin as the chief medicine in combination with Chinese drugs Myelodysplasia and acute leukemia as late complications of marrow failure: future prospects for leukemia prevention. Prognostic value of telomere attrition in patients with aplastic anemia. High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group Clinical course of non-severe aplastic anemia in adults Anemia of Central Origin Risk factors for cytomegalovirus retinitis following bone marrow transplantation from unrelated donors in patients with severe aplastic anemia or myelodysplasia Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis Nontransplant therapy for bone marrow failure Immune dysregulation in myelodysplastic syndrome Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Ne Natural history of transfusion-independent non-severe aplastic anemia in children Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling? Success of allogeneic marrow transplantation for children with severe aplastic anaemia Outcomes of matched sibling and alternative donor stem cell transplantation for 26 children with severe aplastic anemia Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software